Since CBD oil has not been FDA approved as a cure or treatment for any disease, CBD companies do not make or support any medical claims related to hemp CBD oil. Many reputable clinical publications have published their findings on CBD, so we highly recommend that you do your own research on cannabidiol and hemp CBD oil. Although FDA has not come out with an official statement, the United States Department of Health and Human Services does hold a patent called ‘Cannabinoids as
Antioxidants and Neuroprotectants’ (Patent # 6,630,507). This patent states: Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the
treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for
example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia.Cannabidiol has been studied as an antiepileptic (Carlini et al., J. Clin. Pharmacol.21:417S-427S, 1981; Karler et al., J. Clin. Pharmacol. 21:437S-448S, 1981,
Consroe et al., J. Clin Pharmacol. 21:428S-436S, 1981). Non Psychoactive cannabinoids, such as cannabidiol, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention.